Skip to content

Clinical trials

Completed Phase 2/3 Prostatic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 2/3 Status: Completed Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20031
20042
20052
20063
20071
20091
20101
20111
20123
20131
20164
20171
20182
20191
20201
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ferring Pharmaceuticals3
Michael Graham PhD, MD3
University of California, San Francisco2
A.O.U. Città della Salute e della Scienza1
Abbott1
Andrei Iagaru1
Assiut University1
Austin Health1
Canadian Urology Research Consortium1
Centers for Disease Control and Prevention1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms32
Prostatic Neoplasms, Castration-Resistant3
Neoplasms2
Adenocarcinoma1
Agnosia1
Breast Neoplasms1
Colorectal Neoplasms1
Disease1
Insulin Resistance1
Pain1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.